{
    "id": "1157",
    "question": "A 4-year-old boy with acute lymphoblastic leukemia is admitted to the hospital to undergo allogeneic bone marrow transplantation. Two weeks after the conditioning regimen is started, he develops a temperature of 38.5\u00b0C (101.3\u00b0F). Laboratory studies show:\nHemoglobin 8 g/dL\nLeukocyte count 1400/mm3\nSegmented neutrophils 20%\nEosinophils 0.5%\nLymphocytes 87%\nMonocytes 1%\nPlatelet count 110,000/mm3\nWhich of the following is the most appropriate pharmacotherapy for this patient?\"",
    "options": {
        "A": "Transforming growth factor-\u03b2",
        "B": "Erythropoietin",
        "C": "Interleukin-5",
        "D": "Granulocyte-macrophage colony-stimulating factor"
    },
    "answer": "D",
    "predict": "To address this question, let's break down the scenario step by step: 1. **Patient's Condition**: The patient is a 4-year-old boy with acute lymphoblastic leukemia undergoing allogeneic bone marrow transplantation. Two weeks post-transplantation, he develops a fever (38.5\u00b0C or 101.3\u00b0F), indicating an infection. 2. **Lab Results**: - Low Hemoglobin (8 g/dL): Anemia is common post-transplant due to bone marrow suppression. - Low Leukocyte count (1400/mm3): Neutropenia is a significant concern post-transplant, as it increases the risk of infections. - Lymphocytes are relatively normal, but this doesn't directly address the current fever. - Platelet count is slightly low (110,000/mm3), which can also contribute to bleeding complications but is less directly relevant to the fever. 3. **Fever Post-Transplant**: Fever in the context of recent allogeneic bone marrow transplantation is concerning for infection, particularly due to the immunocompromised state of the patient. 4. **Pharmacotherapy Options**: - **A. Transforming growth factor-\u03b2 (TGF-\u03b2)**: Primarily involved in cell growth and differentiation. Not directly relevant to treating fever or infection. - **B. Erythropoietin**: Stimulates red blood cell production, addressing anemia but not the fever or infection directly. - **C. Interleukin-5 (IL-5)**: Plays a role in the differentiation of eosinophils and is involved in fighting parasites. It is not the primary treatment for fever or neutropenia-related infections. - **D. Granulocyte-macrophage colony-stimulating factor (GM-CSF)**: Stimulates the production of both neutrophils and macrophages, which are crucial for fighting bacterial and fungal infections. Given the patient's neutropenia, GM-CSF is a logical choice to help increase the white blood cell count and combat infections. Given the patient's fever and neutropenia post-transplant, the most appropriate pharmacotherapy is aimed at increasing the production of white blood cells to combat the infection. Therefore, the best choice is: {\"step_by_step_thinking\": \"The patient's low neutrophil count and fever suggest an infection, and GM-CSF is the most appropriate choice to stimulate the production of neutrophils and other white blood cells to combat the infection.\", \"answer_choice\": \"D\"}",
    "snippets": [],
    "scores": [],
    "execution_time": 44.67599058151245
}